Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.10. rezultāts no 99.
358. lappuse
... minutes or by any other suitable method . ( 4 ) Pyrogen - free sodium chloride . Heat sodium chloride for not less than 2 hours at 200 ° C. ( 5 ) Pyrogen - free sodium carbonate . Heat anhydrous sodium carbonate for not less than 4 ...
... minutes or by any other suitable method . ( 4 ) Pyrogen - free sodium chloride . Heat sodium chloride for not less than 2 hours at 200 ° C. ( 5 ) Pyrogen - free sodium carbonate . Heat anhydrous sodium carbonate for not less than 4 ...
364. lappuse
... minutes at 70 ° C. Use test plates to assure the viability of the spores and to determine the amount of spore suspension to be added to each 100 milliliters of agar . Main- tain the spore suspension under refrig- eration . ( 3 ) Method ...
... minutes at 70 ° C. Use test plates to assure the viability of the spores and to determine the amount of spore suspension to be added to each 100 milliliters of agar . Main- tain the spore suspension under refrig- eration . ( 3 ) Method ...
365. lappuse
... minutes at 70 ° C. Use test plates to assure the viabil- ity of the spores and to determine the amount of spore ... minute and a radius of 3.5 centimeters at 27 ° C for 5 days . Determine the amount of sus- pension to be added to each ...
... minutes at 70 ° C. Use test plates to assure the viabil- ity of the spores and to determine the amount of spore ... minute and a radius of 3.5 centimeters at 27 ° C for 5 days . Determine the amount of sus- pension to be added to each ...
381. lappuse
... minutes . ( 3 ) Add 2.0 milliliters of 1.2N hydro- chloric acid . ( 4 ) Add 10.0 milliliters of 0.01N iodine solution , stopper , allow to stand at room temperature for 15 minutes , and proceed as directed in paragraph ( e ) of this ...
... minutes . ( 3 ) Add 2.0 milliliters of 1.2N hydro- chloric acid . ( 4 ) Add 10.0 milliliters of 0.01N iodine solution , stopper , allow to stand at room temperature for 15 minutes , and proceed as directed in paragraph ( e ) of this ...
397. lappuse
... minute for 10 minutes to separate the phases . Remove about 15 milliliters of the upper ( 4 - methyl - 2- pentanone solvent ) phase and proceed as directed in paragraph ( e ) of this sec- tion . cen- ( d ) Preparation of the blank ...
... minute for 10 minutes to separate the phases . Remove about 15 milliliters of the upper ( 4 - methyl - 2- pentanone solvent ) phase and proceed as directed in paragraph ( e ) of this sec- tion . cen- ( d ) Preparation of the blank ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning